[1]
|
Rosen, C.J. and Kessenich, C.R. (1996) Comparative Clinical Pharmacology and Therapeutic Use of Bisphosphonates in Metabolic Bone Diseases. Drugs, 51, 537-551. https://doi.org/10.2165/00003495-199651040-00003
|
[2]
|
Marx, R.E. (2003) Pamidronate (Aredia) and Zoledronate (Zometa) Induced Avascular Necrosis of the Jaws: A Growing Epi-demic. Journal of Oral and Maxillofacial Surgery, 61, 1115-1117.
https://doi.org/10.1016/S0278-2391(03)00720-1
|
[3]
|
Yuh, D.Y., Chang, T.H., Huang, R.Y., Chien, W.C., Lin, F.G. and Fu, E. (2014) The National-Scale Cohort Study on Bisphosphonate-Related Osteonecrosis of the Jaw in Taiwan. Journal of Dentistry, 42, 1343-1352.
https://doi.org/10.1016/j.jdent.2014.05.001
|
[4]
|
Brierly, G.I., Ren, J., Baldwin, J., Saifzadeh, S., Theodoropoulos, C., Tsurkan, M.V., Lynham, A., Hsu, E., Nikolarakos, D., Werner, C., et al. (2019) Investigation of Sustained BMP De-livery in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ) in a Rat Model. Macromolecular Bi-oscience, 19, e1900226.
https://doi.org/10.1002/mabi.201900226
|
[5]
|
(2016) Scottish Dental Clinical Effectiveness Programme (SDCEP) Achieves NICE Accreditation. Evidence-Based Dentistry, 17, 62. https://doi.org/10.1038/sj.ebd.6401176
|
[6]
|
Drudge-Coates, L., Van den Wyngaert, T., Schiødt, M., van Muilekom, H.A.M., Demonty, G. and Otto, S. (2020) Preventing, Identifying, and Managing Medication-Related Osteonecrosis of the Jaw: A Practical Guide for Nurses and Other Allied Healthcare Professionals. Support Care Cancer, 28, 4019-4029.
https://doi.org/10.1007/s00520-020-05440-x
|
[7]
|
Fliefel, R., Tröltzsch, M., Kühnisch, J., Ehrenfeld, M. and Otto, S. (2015) Treatment Strategies and Outcomes of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) with Characterization of Patients: A Systematic Review. International Journal of Oral & Maxillofacial Surgery, 44, 568-585. https://doi.org/10.1016/j.ijom.2015.01.026
|
[8]
|
Marx, R.E. (2014) A Decade of Bisphosphonate Bone Complica-tions: What It Has Taught Us about Bone Physiology. The International Journal of Oral & Maxillofacial Implants, 29, e247-258. https://doi.org/10.11607/jomi.te61
|
[9]
|
Cackowski, F.C. and Roodman, G.D. (2007) Perspective on the Osteoclast: An Angiogenic Cell? Annals of the New York Academy of Sciences, 1117, 12-25. https://doi.org/10.1196/annals.1402.073
|
[10]
|
Favot, C.L., Forster, C. and Glogauer, M. (2013) The Effect of Bisphosphonate Therapy on Neutrophil Function: A Potential Biomarker. International Journal of Oral & Maxillofacial Surgery, 42, 619-626.
https://doi.org/10.1016/j.ijom.2012.12.011
|
[11]
|
Pabst, A.M., Ziebart, T., Ackermann, M., Konerding, M.A. and Walter, C. (2014) Bisphosphonates’ Antiangiogenic Potency in the Development of Bisphosphonate-Associated Oste-onecrosis of the Jaws: Influence on Microvessel Sprouting in an in Vivo 3D Matrigel Assay. Clinical Oral Investigations, 18, 1015-1022.
https://doi.org/10.1007/s00784-013-1060-x
|
[12]
|
Nakamura, K., Fukumoto, T., Fukui, T., Sakatani, T., Atsuta, T., Kato, T., Ito, M., Inoue, K. and Terai, A. (2016) A Case of Bisphosphonate-Related Osteonecrosis of the Jaw with Dif-ficulty in Treatment. Hinyokika Kiyo, 62, 39-44.
|
[13]
|
Bramati, A., Girelli, S., Farina, G., Dazzani, M.C., Torri, V., Moretti, A., Piva, S., Dimaiuta, M. and La Verde, N. (2015) Prospective, Mono-Institutional Study of the Impact of a Systematic Prevention Program on Incidence and Outcome of Osteonecrosis of the Jaw in Patients Treated with Bisphosphonates for Bone Metastases. Journal of Bone and Mineral Metabolism, 33, 119-124. https://doi.org/10.1007/s00774-014-0566-x
|
[14]
|
Kalyan, S., Wang, J., Quabius, E.S., Huck, J., Wiltfang, J., Baines, J.F. and Kabelitz, D. (2015) Systemic Immunity Shapes the Oral Microbiome and Susceptibility to Bisphospho-nate-Associated Osteonecrosis of the Jaw. Journal of Translational Medicine, 13, Article No. 212. https://doi.org/10.1186/s12967-015-0568-z
|
[15]
|
Soundia, A., Hadaya, D., Esfandi, N., Gkouveris, I., Christensen, R., Dry, S.M., Bezouglaia, O., Pirih, F., Nikitakis, N., Aghaloo, T., et al. (2018) Zoledronate Impairs Socket Healing af-ter Extraction of Teeth with Experimental Periodontitis. Journal of Dental Research, 97, 312-320. https://doi.org/10.1177/0022034517732770
|
[16]
|
Mozzati, M., Arata, V. and Gallesio, G. (2013) Tooth Extraction in Osteoporotic Patients Taking Oral Bisphosphonates. Osteoporosis International, 24, 1707-1712. https://doi.org/10.1007/s00198-012-2239-8
|
[17]
|
罗号, 刘忠龙, 李晓光, 孟箭, 何悦. 双膦酸盐相关性颌骨坏死发病机制的研究进展[J]. 口腔医学, 2021, 41(4): 373-376.
|
[18]
|
Campisi, G., Fedele, S., Fusco, V., Pizzo, G., Di Fede, O. and Bedogni, A. (2014) Epidemiology, Clinical Manifestations, Risk Reduction and Treatment Strategies of Jaw Osteonecrosis in Cancer Patients Exposed to Antiresorptive Agents. Future Medicine, 10, 257-275. https://doi.org/10.2217/fon.13.211
|
[19]
|
Di Fede, O., Panzarella, V., Mauceri, R., Fusco, V., Bedogni, A., Lo Muzio, L., Sipmo Onj, B. and Campisi, G. (2018) The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention. BioMed Research International, 2018, Article ID: 2684924. https://doi.org/10.1155/2018/2684924
|
[20]
|
Author (2018) ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: Prevenzione, diagnosi, farma-covigilanza, trattamento. Alessandria, 5 maggio 2018. Minerva Stomatologica, 67, 1-45.
|
[21]
|
Ruggiero, S.L., Dodson, T.B., Aghaloo, T., Carlson, E.R., Ward, B.B. and Kademani, D. (2022) American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. Journal of Oral and Maxillo-facial Surgery, 80, 920-943. https://doi.org/10.1016/j.joms.2022.02.008
|
[22]
|
Vandone, A.M., Donadio, M., Moz-zati, M., Ardine, M., Polimeni, M.A., Beatrice, S., Ciuffreda, L. and Scoletta, M. (2012) Impact of Dental Care in the Prevention of Bisphosphonate-Associated Osteonecrosis of the Jaw: A Single-Center Clinical Experience. Annals of Oncology, 23, 193-200. https://doi.org/10.1093/annonc/mdr039
|
[23]
|
Nicolatou-Galitis, O., Papadopoulou, E., Vardas, E., Kouri, M., Galiti, D., Galitis, E., Alexiou, K.E., Tsiklakis, K., Ardavanis, A., Razis, E., et al. (2020) Alveolar Bone Histological Necrosis Observed Prior to Extractions in Patients, Who Received Bone-Targeting Agents. Oral Dis-eases, 26, 955-966. https://doi.org/10.1111/odi.13294
|
[24]
|
Ruggiero, S.L., Dodson, T.B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B. and O’Ryan, F. (2014) American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update. Journal of Oral and Maxillofacial Surgery, 72, 1938-1956. https://doi.org/10.1016/j.joms.2014.04.031
|
[25]
|
Zhang, X., Hamadeh, I.S., Song, S., Katz, J., Moreb, J.S., Langaee, T.Y., Lesko, L.J. and Gong, Y. (2016) Osteonecrosis of the Jaw in the United States Food and Drug Ad-ministration’s Adverse Event Reporting System (FAERS). Journal of Bone and Mineral Research, 31, 336-340. https://doi.org/10.1002/jbmr.2693
|
[26]
|
Lehenkari, P.P., Kellinsalmi, M., Näpänkangas, J.P., Ylitalo, K.V., Mön-kkönen, J., Rogers, M.J., Azhayev, A., Väänänen, H.K. and Hassinen, I.E. (2002) Further Insight into Mechanism of Action of Clodronate: Inhibition of Mitochondrial ADP/ATP Translocase by a Nonhydrolyzable, Adenine-Containing Metabolite. Molecular Pharmacology, 61, 1255-1262.
https://doi.org/10.1124/mol.61.5.1255
|
[27]
|
Veszelyné Kotán, E., Bartha-Lieb, T., Parisek, Z., Meskó, A., Vaszilkó, M. and Hankó, B. (2019) Database Analysis of the Risk Factors of Bisphosphonate-Related Osteonecrosis of the Jaw in Hungarian Patients. BMJ Open, 9, e025600.
https://doi.org/10.1136/bmjopen-2018-025600
|
[28]
|
Kanwar, N., Bakr, M.M., Meer, M. and Siddiqi, A. (2020) Emerging Therapies with Potential Risks of Medicine-Related Osteonecrosis of the Jaw: A Review of the Literature. British Dental Journal, 228, 886-892.
https://doi.org/10.1038/s41415-020-1642-3
|
[29]
|
Heim, N., Warwas, F.B., Wilms, C.T., Reich, R.H. and Martini, M. (2017) Vitamin D (25-OHD) Deficiency May Increase the Prevalence of Medication-Related Osteonecrosis of the Jaw. Journal of Cranio-Maxillofacial Surgery, 45, 2068-2074. https://doi.org/10.1016/j.jcms.2017.09.015
|
[30]
|
Bedogni, A., Bettini, G., Bedogni, G., Basso, D., Gatti, D., Va-lisena, S., Brunello, A., Sorio, M., Berno, T., Giannini, S., et al. (2019) Is Vitamin D Deficiency a Risk Factor for Oste-onecrosis of the Jaw in Patients with Cancer? A Matched Case-Control Study. Journal of Cranio-Maxillofacial Surgery, 47, 1203-1208.
https://doi.org/10.1016/j.jcms.2019.03.007
|
[31]
|
Kos, M. (2015) Incidence and Risk Predictors for Osteonecrosis of the Jaw in Cancer Patients Treated with Intravenous Bisphosphonates. Archives of Medical Science, 11, 319-324. https://doi.org/10.5114/aoms.2015.50964
|
[32]
|
Sarasquete, M.E., González, M., San Miguel, J.F. and García-Sanz, R. (2009) Bisphosphonate-Related Osteonecrosis: Genetic and Acquired Risk Factors. Oral Diseases, 15, 382-387. https://doi.org/10.1111/j.1601-0825.2009.01568.x
|
[33]
|
Steller, D., Herbst, N., Pries, R., Juhl, D. and Hakim, S.G. (2019) Positive Impact of Platelet-Rich Plasma and Platelet-Rich Fibrin on Viability, Migration and Proliferation of Os-teoblasts and Fibroblasts Treated with Zoledronic Acid. Scientific Reports, 9, Article No. 8310. https://doi.org/10.1038/s41598-019-43798-z
|
[34]
|
张圣敏, 曹长红, 刘超. 浓缩生长因子负载脂肪干细胞预防SD大鼠双膦酸盐类药物相关性颌骨骨坏死[J]. 中国组织工程研究, 2021, 25(19): 2982-2987.
|
[35]
|
Watanabe, J., Sakai, K., Urata, Y., Toyama, N., Nakamichi, E. and Hibi, H. (2020) Extracellular Vesicles of Stem Cells to Prevent BRONJ. Journal of Dental Research, 99, 552-560. https://doi.org/10.1177/0022034520906793
|
[36]
|
Zang, X., He, L., Zhao, L., He, Y., Xiao, E. and Zhang, Y. (2019) Adipose-Derived Stem Cells Prevent the Onset of Bisphospho-nate-Related Osteonecrosis of the Jaw through Transforming Growth Factor β-1-Mediated Gingival Wound Healing. Stem Cell Research & Therapy, 10, Article No. 169. https://doi.org/10.1186/s13287-019-1277-y
|
[37]
|
Zhao, D., Xiao, D., Liu, M., Li, J., Peng, S., He, Q., Sun, Y., Xiao, J. and Lin, Y. (2022) Tetrahedral Framework Nucleic Acid Carrying Angiogenic Peptide Prevents Bisphosphonate-Related Osteonecrosis of the Jaw by Promoting Angiogenesis. International Journal of Oral Science, 14, Article No. 23. https://doi.org/10.1038/s41368-022-00171-7
|
[38]
|
Oh, J.S. and Kim, S.G. (2017) Collagen Sponge and rhBMP-2 Improve Socket Healing in Rats Treated with Zoledronic Acid. Brazilian Oral Research, 31, e99. https://doi.org/10.1590/1807-3107bor-2017.vol31.0099
|
[39]
|
Tanaka, Y., Aung, K.T., Ono, M., Mikai, A., Dang, A.T., Hara, E.S., Tosa, I., Ishibashi, K., Ono-Kimura, A., Nawachi, K., et al. (2021) Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-Like Mouse Model by E-rhBMP-2 Con-taining Artificial Bone Graft Administration. International Journal of Molecular Sciences, 22, Article 12823. https://doi.org/10.3390/ijms222312823
|
[40]
|
Sarkarat, F., Modarresi, A., Chiniforush, N., Yazdanparast, L. and Rakhshan, V. (2019) Efficacy of Photodynamic Therapy in Minimizing Bisphosphonate-Related Osteonecrosis of the Jaws after Dental Extraction: A Preliminary Animal Study. Journal of Oral and Maxillofacial Surgery, 77, 307-314. https://doi.org/10.1016/j.joms.2018.09.036
|
[41]
|
Sarkarat, F., Modarresi, A., Riyahi, A., Mortazavi, P., Tabandeh, F. and Rakhshan, V. (2022) Efficacy of Hyaluronic Acid, Absorbable Collagen Sponge, and Their Combination in Mini-mizing Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ) after Dental Extraction: A Preliminary Animal His-tomorphometric Study. Maxillofacial Plastic and Reconstructive Surgery, 44, Article No. 8. https://doi.org/10.1186/s40902-022-00337-7
|
[42]
|
Paulo, S., Laranjo, M., Paula, A., Abrantes, A.M., Martins, J., Marto, C.M., Coelho, A., Casalta-Lopes, J., Carvalho, L., Carrilho, E., et al. (2020) Calcium Phosphate Ceramics Can Prevent Bisphosphonate-Related Osteonecrosis of the Jaw. Materials, 13, Article 1955. https://doi.org/10.3390/ma13081955
|
[43]
|
Castro, M., Torres, P., Solano, L., Córdova, L.A. and Torres, V.A. (2019) Histatin-1 Counteracts the Cytotoxic and Antimigratory Effects of Zoledronic Acid in Endothelial and Osteo-blast-Like Cells. Journal of Periodontology, 90, 766-774. https://doi.org/10.1002/JPER.18-0644
|
[44]
|
Otto, S., Pautke, C., Arens, D., Poxleitner, P., Eberli, U., Nehrbass, D., Zeiter, S. and Stoddart, M.J. (2020) A Drug Holiday Re-duces the Frequency and Severity of Medication-Related Osteonecrosis of the Jaw in a Minipig Model. Journal of Bone and Mineral Research, 35, 2179-2192. https://doi.org/10.1002/jbmr.4119
|
[45]
|
Movahedian Attar, B., Razavi, S.M., Daneshmand, M. and Davoudi, A. (2020) Protective Effects of Resveratrol against Osteonecrosis at the Extraction Site in Bisphosphonate-Treated Rats. International Journal of Oral & Maxillofacial Surgery, 49, 1518-1522. https://doi.org/10.1016/j.ijom.2020.02.019
|
[46]
|
Koneski, F., Popovic-Monevska, D., Gjorgoski, I., Krajoska, J., Popovska, M., Muratovska, I., Velickovski, B., Petrushevska, G. and Popovski, V. (2018) In vivo Effects of Geranylge-raniol on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws. Journal of Cranio-Maxillofacial Sur-gery, 46, 230-236.
https://doi.org/10.1016/j.jcms.2017.11.007
|
[47]
|
沈亚俊. 香叶基香叶醇治疗大鼠双膦酸盐相关性颌骨坏死的研究[D]: [硕士学位论文]. 佳木斯: 佳木斯大学, 2017.
|
[48]
|
Monteiro, C.G.J., Vieira, E.M., Emerick, C., Azevedo, R.S., Pascoal, V.A.B., Homsi, N. and Lins, R.X. (2021) Ozonated Oil Effect for Prevention of Medication-Related Os-teonecrosis of the Jaw (MRONJ) in Rats Undergoing Zoledronic Acid Therapy. Clinical Oral Investigations, 25, 6653-6659. https://doi.org/10.1007/s00784-021-03951-3
|
[49]
|
Adachi, N., Ayukawa, Y., Yasunami, N., Furuhashi, A., Imai, M., Sanda, K., Atsuta, I. and Koyano, K. (2020) Preventive Effect of Fluvastatin on the Development of Medi-cation-Related Osteonecrosis of the Jaw. Scientific Reports, 10, Article No. 5620. https://doi.org/10.1038/s41598-020-61724-6
|
[50]
|
Demircan, S. and Isler, S.C. (2020) Changes in Serological Bone Turnover Markers in Bisphosphonate Induced Osteonecrosis of the Jaws: A Case Control Study. Nigerian Journal of Clinical Practice, 23, 154-158.
|